| Typicality: | 0.503 |
| Saliency: | 0.289 |
| carefully | 3 | manner |
| in order to guide future clinical trial design | 3 | purpose |
| from scenarios | 2 | other |
| recommendation → be → described | 13 |
| recommendation → be → elaborated | 7 |
| negative | neutral | positive |
| 0.059 | 0.767 | 0.174 |
| Raw frequency | 20 |
| Normalized frequency | 0.289 |
| Modifier score | 0.900 |
| Perplexity | 151.285 |